Medical and Pharmaceutical Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment The stock was up by about 200% during early trading hours Rowan DunneFebruary 6, 2025
AI and Autonomy Light AI develops smartphone tech for diagnosing severe throat infection The Vancouver-based medical equipment company completed its IPO earlier this month Rowan DunneJanuary 29, 2025
Medical and Pharmaceutical Baird Medical rubs shoulders with investors at prestigious healthcare event, sees 77% spike The annual J.P. Morgan Healthcare Conference is held in San Francisco Rowan DunneJanuary 17, 2025
Medical and Pharmaceutical ‘ORACLE’ lung cancer test helps predict survival with superior precision British researchers just published an extensive study on the tissue biopsy in Nature Cancer Rowan DunneJanuary 13, 2025
Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
AI and Autonomy Predictive Oncology shares rise 71% as takeover by Renovaro is announced Both companies are focused on AI-powered drug discovery Rowan DunneJanuary 6, 2025
Medical and Pharmaceutical Russia develops mRNA cancer vaccine for citizens, skepticism lingers An absence of data has rendered the announcement questionable Rowan DunneJanuary 2, 2025
Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Cannabis Morocco launches nation’s first cannabinoid drug for epilepsy treatment Morocco harvested 294 metric tons of legal cannabis last year Rowan DunneDecember 20, 2024
Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024